Failure of second-line therapy to modify survival in relapsed squamous cell carcinoma of the head and neck

M. Merlano, A. Grimaldi, L. Bonelli, R. Tatarek, R. Rosso

Research output: Contribution to journalArticlepeer-review

Abstract

Between August 1979 and August 1984, 47 consecutive patients with recurrent squamous cell carcinoma of the head and neck entered one of three consecutive second-line treatments. Response rates with each treatment were very different (70% vs 5.9% vs 75%), but there was no statistical difference in actuarial survival (survival: 30% vs 29% vs 20%, respectively, at 260 days). In light of this observation, the efficacy of the second-line therapy appears doubtful and the survival of relapsing patients seems unrelated to the response achieved.

Original languageEnglish
Pages (from-to)367-370
Number of pages4
JournalTumori
Volume71
Issue number4
Publication statusPublished - 1985

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Failure of second-line therapy to modify survival in relapsed squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Cite this